📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. (2020)

First Author: Angelidou A

Attributed to: IMPRINT: IMmunising PRegnant women and INfants neTwork funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.11.060

PubMed Identifier: 32005538

Publication URI: http://europepmc.org/abstract/MED/32005538

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 9

ISSN: 0264-410X